George Tsokos
Rheumatology · Boston, MANPI 1508884024
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.1%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Merck at 34.0% of the total.
Across 28 payments — averaging $1769.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$17K
- Novartis Pharma AG$14K
- UCB SA$9K
- Otsuka Pharmaceutical Co., Ltd.$5K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Janssen Research & Development, LLC$1K
- plus $1K from 2 others
Across 36 payments — averaging $84,518 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$2.8M
- Pfizer$247K
What the payments were for
- Consulting fees$23,34947%
- Speaking & faculty fees$7,22715%
- Travel & lodging$18,51037%
- Food & beverage$4621%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 9 | $16,855 |
| Novartis Pharma AG | 6 | $14,432 |
| UCB SA | 6 | $8,891 |
| Otsuka Pharmaceutical Co., Ltd. | 3 | $5,330 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,500 |
| Janssen Research & Development, LLC | 1 | $1,414 |
| Eli Lilly | 1 | $1,000 |
| Gilead | 1 | $125 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIN457_COSENTYX_DERMATOLOGY$14,242
- STELARA$1,414
- Tremfya$1,414
How this compares
$49,547 in reported general payments places this provider in the 85th percentile of 265 rheumatology providers in Massachusetts.
Other rheumatology in Boston
- Marilyn PikeBoston$1.4M
- John StoneBoston$926K
- Lee SimonBoston$600K
- Jeffrey SparksBoston$299K
- Tanya LaidlawBoston$244K
- Tuhina NeogiBoston$242K
- Michael WeinblattBoston$228K
- Michael BrennerBoston$115K
- Zachary WallaceBoston$106K
- Flavia CastelinoBoston$96K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.